Endocarditis Through the Ages—What Has Changed During the Past Two Decades
The Thoracic and Cardiovascular Surgeon · 16.02.2026
DOI: 10.1055/a-2797-9999 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 16.02.2026. Verfasst von Asen Petrov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Heart Centre Dresden University Hospital of the University of Technology Dresden, Dresden, SN, Germany. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Despite developments in the past 20 years in the treatment of native valve (NVE) endocarditis, including the multidisciplinary endocarditis team approach and advances in perioperative care, outcome improvements are lacking. This study compares a contemporary with a historic cohort of NVE patients. All patients undergoing first-time cardiac surgery for NVE in two periods were evaluated in a retrospective observational single-center trial. The historic period included patients from 1998 to 2003 and the contemporary cohort 2021 to 2024. Of the 359 patients who were included, 155 were in the historic cohort (years 1998–2003) and 204 in the contemporary (years 2021–2024). The annual caseload increased significantly from 25.8 to 51.0 annual cases (p < 0.01). Patient baselines changed, being nowadays older (62.6 vs. 55.5 years, p < 0.001), having higher BMI (26.9 kg/m2 vs. 25.3 kg/m2, p < 0.01) and higher EuroSCORE II (8.7% vs. 5.0%, p < 0.001). Accordingly, the preoperative clinical presentation also worsened with an increase in septic embolizations (33.8% vs. 22.6%, p = 0.04) and acute kidney injury (15.2% vs. 1.9%, p < 0.001). Minimally invasive procedures were newly established (41.2% vs. 0%). The contemporary group faced a higher rate of postoperative dialysis, longer intensive care unit stay, and higher perioperative mortality (14.2% vs. 6.5%, p = 0.03). Nonetheless, survival at 1 year was comparable (78.4% vs. 79.9, p = 0.52). Contemporary patients have higher risk profiles and annual caseloads. This translates into increased postoperative morbidity and mortality; however long-term outcomes have remained constant.
Autor:innen und Institutionen
- Department of Cardiac Surgery, Heart Centre Dresden University Hospital of the University of Technology Dresden, Dresden, SN, Germany.
ORCID-Profile: Asen Petrov
Zitieren
APA
Petrov, A., Schöne, P., Taghizadeh-Waghefi, A., Tugtekin, S. M., Matschke, K. E., & Wilbring, M. (2026). Endocarditis Through the Ages—What Has Changed During the Past Two Decades. The Thoracic and Cardiovascular Surgeon. https://doi.org/10.1055/a-2797-9999
Vancouver
Petrov A, Schöne P, Taghizadeh-Waghefi A, Tugtekin SM, Matschke KE, Wilbring M. Endocarditis Through the Ages—What Has Changed During the Past Two Decades. The Thoracic and Cardiovascular Surgeon. 2026. doi:10.1055/a-2797-9999
BibTeX
@article{Petrov2026,
author = {Petrov, Asen and Schöne, Pascal and Taghizadeh-Waghefi, Ali and Tugtekin, Sems-Malte and Matschke, Klaus Ehrhard and Wilbring, Manuel},
title = {Endocarditis Through the Ages—What Has Changed During the Past Two Decades},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
doi = {10.1055/a-2797-9999}
}
EUVIMED